Journals / Türk Kardiyoloji Derneği Arşivi / 2003 / Cilt: 31 - Sayı: 8

Apo CIII levels in Turkish adults: Association with coronary risk and metabolic syndrome

Türk erişkinlerinde apo CIII düzeyleri: Koroner risk ve metabolik sendrom ile ilişkileri

Pages
440–450
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Total apoC-III and nonHDL apoC-III proved to be significantly (p trend

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Since apolipoprotein C-III (apoC-III) has been proposed to indicate coronary risk in healthy subjects, we studied cross-sectionally in a population sample representative of Turkish adults whether serum levels of total apoC-III or its components were independent markers of prevalent coronary heart disease (CHD) or were related to the metabolic syndrome (MS).
📊
Key Findings & Data:In 857 unselected participants of the Turkish Adult Risk Factor Survey in 2001, apoC-III and other risk variables were evaluated.
💡
Conclusion & Impact:Total apoC-III and nonHDL apoC-III proved to be significantly (p trend
🔬Design:Survey & Empirical Study
📍Scope:2001 Verileri
⚙️Variables:Domain Parameters

Abstract

Since apolipoprotein C-III (apoC-III) has been proposed to indicate coronary risk in healthy subjects, we studied cross-sectionally in a population sample representative of Turkish adults whether serum levels of total apoC-III or its components were independent markers of prevalent coronary heart disease (CHD) or were related to the metabolic syndrome (MS). In 857 unselected participants of the Turkish Adult Risk Factor Survey in 2001, apoC-III and other risk variables were evaluated. CHD was diagnosed on the basis of clinical findings and Minnesota coding of resting ECGs. The sample consisted of middle-aged and elderly adults, 42% of whom had MS identified by criteria of the ATP III. ApoC-III values were measured by turbidimetric immunoassay. Mean concentrations for nonHDL apoC-III in men and women were 6.4 and 6.2 mg/dl, respectively, and for apoC-III in HDL were 6.2 and 6.3 mg/dl, respectively. Both fractions of apoC-III were significantly correlated with lipids, lipoproteins, apo B, anthropometric measures and blood pressures in both sexes. Correlations of both were high with serum triglycerides (rs = around 0.70) and apo B (rp = around 0.37). Total apoC-III as well as both fractions were significantly correlated in women also with C-reactive protein (rs = around 0.20, p7.0 mg/dl) as opposed to lower levels of nonHDL apoC-III indicated the presence of hypertriglyceridemic hyperapo B with an age-adjusted OR of 13.8; it indicated the presence of metabolic syndrome with 4.66-fold likelihood. Total apoC-III and nonHDL apoC-III proved to be significantly (p trend

Özet

Çalışmanın amacı düşük kolesterol düzeyleri fakat yüksek metabolik sendrom (MS) prevalansına sahip olan Türk erişkinlerinde, total apolipoprotein CIII (apo CIII) ve alt fraksiyonlarının prevalan koroner kalp hastalığının (KKH) bağımsız belirteci olup olmadığını veya metabolik sendromla ilişkili değişkenleri yansıtıp yansıtmadığını kesitsel olarak incelemekti. 2001 TEKHARF taraması kohortunu temsil eden 857 katılımcıda, apo CIII ve diğer risk faktörleri değerlendirildi. KKH teşhisi, klinik bulgular ve istirahat elektrokardiyogramının Minnesota kodlamasına göre yapıldı. Çalışma grubu 33-82 yaşları arasındaki kadın ve erkeklerden oluştu. ATP III kriterine göre grubun %42'sinde metabolik sendrom saptandı. Ortalama bel çevresi erkeklerde 89.4 cm, kadınlarda 92.9 cm bulundu. Apo CIII türbidimetrik immunassay ile ölçüldü. Erkek ve kadınlarda ortalama HDLdışı-apo CIII sırasıyla 6.4 ve 6.2 mg/dl, HDL apo CIII ise 6.2 ve 6.3 mg/dl idi. HDLdışı-apoCIII düzeyleri Batılı toplumlardaki değerlere benzer, HDLapoCIII düzeyleri ise daha yüksek bulundu. İki cinste de apo CIII'ün her iki fraksiyonu da lipidler, lipoproteinler, apo B, antropometrik ölçümler, sistolik ve diyastolik kan basıncı ile anlamlı ilişki sergiledi. Her iki apo CIII fraksiyonunun serum trigliseridleri (rs = 0.70 ) ve apo B (rp = 0.37) ile ilişkisi oldukça kuvvetli idi. Toplam apo CIII ve her iki fraksiyonu, kadınlarda proinflamatuar C-reaktif protein ile zayıf bir ilişki (rs =0.20, p7 mg/dL değerler, hipertrigliseridemik hiperapo B varlığını yaş ayarlı 13.8 Odds oranı (OO) ile belirledi. Total ve HDLdışı-apoCIII, yaş, LDL- ve HDL- kolesterol ayarlamaları yapıldıktan sonra dahi erkeklerde prevalan KKH ile anlamlı (p trend

🔖

Cite This Article

TOPRAK, S., ONAT, A., FOBKER, M., ASSMANN, G., HERGENÇ, G., SANSOY, V., CEYHAN, K. (2022). Apo CIII levels in Turkish adults: Association with coronary risk and metabolic syndrome. Türk Kardiyoloji Derneği Arşivi, Cilt: 31 - Sayı: 8, 440–450. https://ajindex.com/articles/633847

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Wang C, McConathy WJ, Kloer HU, Alaupovic P: Modulation of lipoprotein lipase activity by apolipoproteins.J Clin Invest 1985
  2. 90 2. Sehayek E, Eisenberg S: Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low-density lipoprotein receptor pathway. J Biol Chem 1991
  3. 18259-67 3. Uiterwaal CSPM, Grobbee DE, Witteman JCM, et al: Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med 1994
  4. 83 4. Ginsberg HN, Jones J, Blaner WS, et al.: Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler Thromb Vasc Biol 1995
  5. 38 5. Sacks FM, Alaupovic P, Moye LA, et al: VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial, Circulation 2000
  6. 92 6. Luc G, Fievet C, Arveiler D, et al: Apolipoproteins C-III and E in apo-B- and non-apo-B-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. J Lipid Res 1996
  7. 17 7. Waterworth DM, Talmud PJ, Luan J, et al: Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men. Biochim Biophys Acta. 2003
  8. 6 8. Talmud PJ, Hawe E, Martin S, et al: Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet. 2002
  9. 46 9. Minihane AM, Finnegan YE, Talmud P, Leigh-Firbank EC, Williams CM: Influence of the APOC3 -2854T>G polymorphism on plasma lipid levels: effect of age and gender. Biochim Biophys Acta. 2002
  10. 4 10. Li WW, Dammerman MM, Smith JD, Metzger S, Breslow JL, Leff T: Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Invest 1995
  11. 5 11. Devlin CM, Prenger VL, Miller M: Linkage of the apo CIII microsatellite with isolated low high-density lipoprotein cholesterol. Hum Genet 1998
  12. 81 12. Tilly P, Sass C, Vincent-Viry M, Aguillon D, Siest G, Visvikis S: Biological and genetic determinants of serum apoC-III concentration: reference limits from the Stanislas Cohort. J Lipid Res. 2003
  13. 6 13. Thompson GR: Angiographic evidence for the role of triglyceride-